FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
Form Serial Number
:
DA20250815E00422
1.
Date of relevant event
:
14/08/2025
(dd/mm/yyyy)
2.
Date when director became aware of the relevant event/ interest in the shares (if later)
:
(dd/mm/yyyy)
3.
Stock code
:
02186
4.
Name of listed corporation
:
Luye Pharma Group Ltd.
5.
Class of shares
:
Ordinary Shares
6.
Number of issued shares in class
:
3,835,757,787
7.
Name of director (English) as printed on HKID Card/Passport
:
(
Surname
)
Liu
(
Other names
)
Dianbo
10.
Name of director (Chinese)
:
刘殿波
11.
Chinese Character Code as printed on HKID Card
:
24.
Details of relevant event
:
Brief description of relevant event
Capacity in which shares were/are held
Number of shares bought/sold or involved
Currency of transaction
On Exchange
Off Exchange
Before relevant event
After relevant event
Highest price (per share)
Average price (per share)
Average consideration (per share)
Consideration code
Long position
1213
The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
2301
Trustee
2301
Trustee
Short position
1213
The number of shares in which you are interested has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
2301
Trustee
2301
Trustee
25.
Total shares in listed corporation immediately before the relevant event
:
Total number of shares
Percentage figure (%)
Long position
1,246,108,703
32.94
Short position
212,229,950
5.61
26.
Total shares in listed corporation immediately after the relevant event
:
Total number of shares
Percentage figure (%)
Long position
1,246,108,703
32.49
Short position
212,229,950
5.53
27.
Capacity in which interests disclosed in Box 26 are held
:
Code describing capacity
Number of shares
2301
Trustee
Long position
1,246,108,703
Short position
212,229,950
28.
Further information in derivative interests in listed corporation
:
Derivatives code
Exercise period (dd/mm/yyyy)
Consideration - if derivatives granted by listed corporation
Number of shares
Begins
Ends
Currency
Price for grant
Currency
Exercise price
Currency
Price on assignment
Short position
4105
Unlisted derivatives - Physically settled
212,229,950
29.
Further information in relation to interests of children under 18 and/or spouse
:
Child/Spouse
Name of child/spouse
Number of shares
30.
Further information in relation to interests of corporations controlled by Director
:
Name of controlled corporation
Address and place of incorporation
Name of controlling person
% control
Direct interest (Y/N)
Number of shares
Shorea LBG
Helvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)
Liu Dianbo
100.00
N
Long position
1,246,108,703
Short position
212,229,950
Ginkgo (PTC) Limited
Helvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)
Shorea LBG
100.00
N
Long position
1,246,108,703
Short position
212,229,950
Nelumbo Investments Limited
Helvetia Court, South Esplanade, St Peter Port, Guernsey (Guernsey)
Ginkgo (PTC) Limited
100.00
N
Long position
1,246,108,703
Short position
212,229,950
Luye Life Sciences Group Ltd
Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda (Bermuda)
Nelumbo Investments Limited
70.00
N
Long position
1,246,108,703
Short position
212,229,950
Luye Pharma Holdings Ltd.
Cricket Square, Hutchins Drive, PO Box 2681, Grand Cayman, KY1-1111, Cayman Islands (Cayman Islands)
Luye Life Sciences Group Ltd
100.00
N
Long position
1,246,108,703
Short position
212,229,950
LuYe Pharmaceutical International Co., Ltd.
PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)
Luye Pharma Holdings Ltd.
100.00
N
Long position
1,246,108,703
Short position
212,229,950
LuYe Pharmaceutical Investment Co., Ltd.
PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands)
LuYe Pharmaceutical International Co., Ltd.
100.00
Y
Long position
1,246,108,703
Short position
212,229,950
31.
Further information in relation to interests held by Director jointly with another person
:
Name of joint shareholder
Address
Number of shares
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust
:
Names of Trust
Address
Status code
Number of shares
33.
Further information from a party to an agreement under Section 317
(Please see Notes for further information required)
:
Names of other parties
Address
Number of shares
Total number of shares in which a director is interested under sections 317 and 318
34.
Supplementary information
:
Box 17: The decrease in the percentage level of Mr. Liu's interest was due to an increase in the total number of issued shares of the Company from 3,782,838,398 to 3,835,757,787 in relation to the conversion of the US$100,000,000 5.85 per cent. convertible bonds due 2025 in the principal amount of US$25,000,000 at the conversion price of HK$3.672 per Share, which was published on the website of Singapore Exchange Securities Trading Limited on 14 August 2025.
35.
Log/Serial Number of the previous form
:
36.
Number of concert party document(s) under section 317 attached/uploaded
:
Date of filing this Form 3A
:
15/08/2025
(dd/mm/yyyy)